Jane Street’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$552K Buy
+7,600
New +$585K ﹤0.01% 7785
2026
Q1
– Sell
-100,700
Closed -$7.95M – 11487
2025
Q4
$7.95M Buy
100,700
+95,200
+1,731% +$8.24M ﹤0.01% 2613
2025
Q3
$504K Buy
+5,500
New +$448K ﹤0.01% 7845
2024
Q2
– Sell
-302,500
Closed -$20.9M – 9432
2024
Q1
$20.9M Buy
+302,500
New +$18.3M ﹤0.01% 1188
2022
Q1
– Sell
-4,700
Closed -$217K – 10219
2021
Q4
$217K Buy
+4,700
New +$202K ﹤0.01% 8697

Other funds holding ANIP

Jane Street's ANIP Position: Q1 2026 in Review

Jane Street sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 25,657 shares — an estimated $2M sold.

Jane Street first reported a position in ANIP in Q1 2014 and held it in 18 quarters. The position peaked at $12.3M in Q3 2025. 282 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Jane Street reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 25,657 ANI Pharmaceuticals shares in Q1 2026, an estimated $2M.
  • Jane Street first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 18 quarters.
  • Jane Street's ANI Pharmaceuticals position peaked at $12.3M in Q3 2025.
  • 282 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.